Doxorubicin-Polyglycerol-Nanodiamond Conjugate Is a Cytostatic Agent That Evades Chemoresistance and Reverses Cancer-Induced Immunosuppression in Triple-Negative Breast Cancer

Journal of Nanobiotechnology - United Kingdom
doi 10.1186/s12951-019-0541-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cholecalciferol-Peg Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer

AAPS PharmSciTech
EvolutionEcologySystematicsCrop ScienceAquatic ScienceBehaviorPharmaceutical ScienceMedicineAgronomyDrug Discovery
2017English

Targeting Stromal Remodeling and Cancer Stem Cell Plasticity Overcomes Chemoresistance in Triple Negative Breast Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Triple-Negative Breast Cancer

2018English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Brachyury, a Vaccine Target, Is Overexpressed in Triple-Negative Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

FZD7 in Triple Negative Breast Cancer Cells

2011English

T‑cadherin Is Associated With Prognosis in Triple‑negative Breast Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy